Clincosm LogoSign in Get a demo

Myelofibrosis (MF)

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis (MF) Trial in Worldwide (Navitoclax, Ruxolitinib, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis (MF)
  • Chandler, Arizona
  • +207 more
Jul 26, 2022

Myelofibrosis (MF) Trial in Korea, Republic of, South Africa, United States (Mivebresib, Navitoclax, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis (MF)
  • Stony Brook, New York
  • +6 more
Mar 23, 2022

Myelofibrosis (MF) Trial in Worldwide (Ruxolitinib, Navitoclax)

Active, not recruiting
  • Myelofibrosis (MF)
  • Birmingham, Alabama
  • +149 more
Nov 5, 2021

Myeloproliferative Tumors (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Toronto (Upper gastrointestinal

Completed
  • Myeloproliferative Neoplasms (MPN)
  • +3 more
  • Upper gastrointestinal endoscopy and Doppler ultrasound
  • Toronto, Ontario, Canada
  • +1 more
Dec 12, 2019

Myelodysplastic Syndrome (MDS), Aplastic Anaemia (AA), Myelofibrosis (MF) Trial in Singapore (Chinese herbal concoction twice a

Completed
  • Myelodysplastic Syndrome (MDS)
  • +3 more
  • Chinese herbal concoction twice a day for 6 months
  • Singapore, Singapore
    Singapore General Hospital
Feb 9, 2017

Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)

Suspended
  • Myelodysplastic Syndrome (MDS)
  • Myelofibrosis (MF)
  • KB004, Monoclonal Antibody
  • Palo Alto, California
  • +8 more
Nov 13, 2015